Purification of an endogenous digitalislike factor from human plasma for structural analysis

Hypertension. 1991 Jun;17(6 Pt 2):923-9. doi: 10.1161/01.hyp.17.6.923.

Abstract

In previous reports, we described the isolation and characterization of an endogenous digitalislike factor (EDLF). In this report, we describe a unique combination of bioassay and large-scale purification methodology that made possible the purification of sufficient quantities of this inhibitor of Na+,K(+)-ATPase for structural analysis. Using an initial XAD-2 extraction and preparative high-performance liquid chromatography followed by a batch enzyme affinity extraction and two subsequent semipreparative chromatographic steps, 300 l of human plasma was processed, yielding 31 micrograms (53 nmol) of pure EDLF and representing purification on a dry weight basis in excess of 0.6 billionfold. Four divergent pieces of evidence, including chromatographic, mass spectrometric, immunoreactive, and binding characteristics, suggested that the EDLF purified in the present study was either ouabain or an isomer of ouabain. This material may represent a plasma-borne, naturally occurring, selective, high-affinity ligand for the digitalis binding site that may play a significant role in the modulation of the sodium pump and thereby cellular electrolyte homeostasis in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies
  • Blood Proteins / chemistry
  • Blood Proteins / immunology
  • Blood Proteins / isolation & purification*
  • Cardenolides
  • Chromatography, High Pressure Liquid
  • Cross Reactions
  • Digoxin*
  • Humans
  • Ouabain / immunology
  • Saponins*
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors
  • Spectrometry, Mass, Fast Atom Bombardment

Substances

  • Antibodies
  • Blood Proteins
  • Cardenolides
  • Saponins
  • digoxin-like factors
  • Ouabain
  • Digoxin
  • Sodium-Potassium-Exchanging ATPase